China Pharmaceutical Grade Weight Loss Peptide Liraglutide, Find details about China Liraglutide Powder, Liraglutide from Pharmaceutical Grade Weight Loss Peptide Liraglutide
Liraglutide is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insuli n secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. and E.U. under the brand name Saxenda as a treatment for adults, who are obese or overweight with at least one weight-relatedcomorbid condition.
Product Name: | Liraglutide |
CAS: | 204656-20-2 |
Other names | Liraglutide |
MF: | C172H265N43O51 |
EINECS: | N/A |
Product Categories: | Vitamins |
Appearance | white powder |
Brand Name: | YYC |
Form | Powder |
Place of Origin: | Shaanxi, China (Mainland) |
Packaging: | Bottle, Can, Drum, Plastic Contain |
Standard: | USP EP JP etc. |
Purity: | 99.0% |
Introduction: | Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates in sulin secretion. |